慢性心力衰竭中的GH疗法:随机对照试验的系统审查和元分析
Nikolaos Theodorakis1,2,3, Georgios Feretzakis3, Magdalini Kreouzi4
1Department of Cardiology & Heart Failure Outpatient Clinic, Sismanogleio-Amalia Fleming General Hospital, Melissia 15127, Greece.
The Journal of clinical endocrinology and metabolism
|November 20, 2024
概括
增长激素 (GH) 治疗对心力衰竭 (HF) 患者有希望,改善心脏功能和运动能力. 需要进一步的事件驱动试验来确认其对艰难临床结果的影响.
科学领域:
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 针对心力衰竭 (HF) 的指导指导医学治疗主要针对神经激素激活.
- 增长激素 (GH) 缺乏与HF患者的较差结果有关.
- 目前正在研究与高血压相关的多种荷尔蒙缺乏症综合征的GH疗法.
研究的目的:
- 评估生长激素 (GH) 治疗在患有心力衰竭 (HF) 的成年患者中的疗效和安全性.
主要方法:
- 在PubMed,Cochrane图书馆和ClinicalTrials.gov进行了系统的文献搜索,遵守PRISMA指南.
- 包括成人HF患者GH治疗的随机,安慰剂控制试验;17项研究符合标准.
- 研究质量由独立审稿人评估,重点是随机化,盲目化和安慰剂控制.
主要成果:
- GH疗法显著改善左心室喷射率 (+3.34%) 和峰值氧气消耗 (+2.84毫升/千克/分钟).
- 纽约心脏协会的班级改善了 (0.44),GH疗法将死亡的复合终点降低了41%,使HF恶化,或心室动脉冲动减轻了41%.
- 亚组分析显示,缺血性心肌病患者的益处更大,基线射出率更高,治疗持续时间更长.
结论:
- GH疗法在心脏功能,运动能力和HF症状方面显著改善.
- 观察到一个统计学上显著的趋势,即改善了硬临床终点.
- 建议进行事件驱动试验,以验证这些发现,并确认GH治疗对高血压的长期影响.
更多相关视频
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
10.4K
09:20Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
6.4K
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
386
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
386
01:26Heart Failure Drugs: Inotropic Agents
521
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
521
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
01:22Heart Failure Drugs: β-Blockers
316
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
316
01:28Mitral Regurgitation IV: Nursing Management
3
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
3
01:21Rheumatic Heart Disease III: Medical Management
3
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
3